As illustrated in Fig. 5B, the responsive release of ZPP in tumor cells competitively inhibits the binding of HO-1 to heme, thereby inhibiting the activity of HO-1 and blocking the antioxidant capacity of tumor cells. This evidence concerns the gene HMOX1 and neoplasm.